Hypothalamic NPY concentrations are elevated before a meal to stimulate appetite, and continuous or repeated central administration of NPY leads readily to obesity, while POMC derived α-melanocyte-stimulating hormone (MSH) counteracts NPY to inhibit feeding and promote negative energy balance [5]. The gene discussed is NPY; the disease is obesity disorder.